Clinical Microbiology Reviews· 2015Q1· Review
Actinomyces and Related Organisms in Human Infections
- 511citations
- Q1SCImago
- 2015year
Short summary
Recent advances, particularly molecular methods, are revealing a widening spectrum of diseases caused by newly described Actinomyces species and related organisms beyond the historically recognized Actinomyces israelii.
AI-generated from the title and abstract; the full text is not read.
Key points
- Numerous novel Actinomyces species have been identified in the last 30 years.
- Advanced molecular methods are crucial for detecting and identifying these organisms.
- Previously unrecognized species are emerging as important causes of human infections.
- The range of diseases caused by Actinomyces and related organisms is expanding.
AI-generated from the title and abstract; the full text is not read.
Abstract
Actinomyces israelii has long been recognized as a causative agent of actinomycosis. During the past 3 decades, a large number of novel Actinomyces species have been described. Their detection and identification in clinical microbiology laboratories and recognition as pathogens in clinical settings can be challenging. With the introduction of advanced molecular methods, knowledge about their clinical relevance is gradually increasing, and the spectrum of diseases associated with Actinomyces and Actinomyces-like organisms is widening accordingly; for example, Actinomyces meyeri, Actinomyces neuii, and Actinomyces turicensis as well as Actinotignum (formerly Actinobaculum) schaalii are emerging as important causes of specific infections at various body sites. In the present review, we have gathered this information to provide a comprehensive and microbiologically consistent overview of the significance of Actinomyces and some closely related taxa in human infections.
The authors' abstract, as published at the source. Clinical Microbiology Reviews, 2015 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Microbiology
MicrobiologyMedicine